eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2017
vol. 21
 
Share:
Share:
abstract:
Review paper

Radiotherapy in testicular germ cell tumours – a literature review

Joanna Jonska-Gmyrek
,
Piotr Peczkowski
,
Wojciech Michalski
,
Grazyna Poniatowska
,
Agnieszka Zolciak-Siwinska
,
Beata Kotowicz
,
Pawel Wiechno
,
Magdalena Golawska
,
Maria Kowalska
,
Tomasz Demkow

Contemp Oncol (Pozn) 2017; 21 (3): 203–208
Online publish date: 2017/09/29
View full text Get citation
 
PlumX metrics:
Testicular germ cell tumours (GCT) represent about 1–2% of malignant in men. The essential therapeutic option for early-stage GCT is radical orchiectomy (RO), except in situations that require immediate chemotherapy in patients with a massive dissemination and unequivocally elevated levels of tumour markers.

Postoperative radiotherapy (PORT) in patients with testicular seminoma in Clinical Stage I (CS I) is one of the treatment options next to active surveillance (AS) and chemotherapy (CHTH). Regardless of the procedure, five-year survival in this group of patients ranges between 97% and 100%.

In the article, we present the literature review pertinent to therapeutic options, with a focus on radiotherapy. We have searched MEDLINE (PubMed) for all studies on patients with GCT treated with radiation therapy during the last 20 years, and the current therapeutic recommendations. We used the following keywords: germ cell tumours, testis, seminoma, non-seminoma, radiotherapy, outcome.
keywords:

germ cell tumours, testis, seminoma, non-seminoma, radiotherapy, outcome

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.